Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:23 PM
Ignite Modification Date:
2025-12-24 @ 2:23 PM
NCT ID:
NCT00285259
Eligibility Criteria:
Inclusion Criteria:
* males and females age 18-65
* 5/6 or 6/6 classic HLA allele-matched donor
* planned GCSF-mobilized peripheral blood stem cell transplant
* CMV-seropositive recipient
* planned transplant with minimal or no T-cell depletion
* Acute Lymphoblastic Leukemia (ALL) in first or second remission; Acute Myeloid Leukemia (AML) in first or second remission; Chronic Myelogenous Leukemia (CML) in first chronic or accelerated phase, or in second chronic phase; Hodgkin's and non-Hodgkin's lymphoma; myelodysplastic syndrome
Exclusion Criteria:
* planned prophylactic cytomegalovirus antiviral therapy
* planned immunosuppression with alemtuzumab (CAMPATH-IH)
* planned prophylactic therapy with CMV immunoglobulin
* autoimmune disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00285259
Study Brief:
Protocol Section:
NCT00285259